Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

Whether low-dose Bacillus Calmette-Guerin (BCG) treatment can reduce the side effects while maintaining efficacy for patients with nonmuscle invasive bladder cancer (NMIBC) is controversial. To investigate whether low-dose BCG treatment can reduce the side effects while maintaining efficacy for pati...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicine (Baltimore)
Prif Awduron: Zeng, Shuxiong, Yu, Xiaowen, Ma, Chong, Zhang, Zhensheng, Song, Ruixiang, Chen, Xin, Sun, Yinghao, Xu, Chuanliang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wolters Kluwer Health 2015
Pynciau:
7300
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008490/
https://ncbi.nlm.nih.gov/pubmed/26656345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002176
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg